Last reviewed · How we verify

NCT05037370

CONTOURA vs WFO Ablation PRK & LASIK

Recruiting now NA Last updated 14 August 2025
What this trial tests

NA trial testing Wave-Front Optimized (WFO) ablation vs Topography-guided (TG) ablation in Refractive Surgery in 400 participants. Currently enrolling.

Timeline
22 April 2021
Primary endpoint
31 December 2026
31 December 2026

Quick facts

Lead sponsor59th Medical Wing
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment400
Start date22 April 2021
Primary completion31 December 2026
Estimated completion31 December 2026
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

59th Medical Wing — full company profile →

Who can join

Adults 21 to 50, any sex, with Refractive Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a prospective randomized contralateral double-masked study. Each patient will be randomized as to which eye undergoes wave-front optimized (WFO) vs. wave-front guided (WFG) during Photorefractive keratectomy (PRK) or Laser-assisted in situ Keratomileusis (LASIK) surgery to determine which ablation profile provides the best visual outcome.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Refractive Surgery

Currently open trials in the same condition.

Other 59th Medical Wing trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05037370.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing